Role of intracellular redox status in apoptosis induction of human T-cell leukemia virus type I-infected lymphocytes by 13-cis-retinoic acid.
暂无分享,去创建一个
Y. Yamaoka | H. Masutani | T. Inamoto | A. Yamauchi | J. Yodoi | Akira Yamauchi | K. Furuke | T. Sasada | Y. Ueda-Taniguchi | Tetsuro Sasada | J. Yodoi | Yoshio Yamaoka | Takashi Inamoto
[1] H. Sies,et al. Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.
[2] K. Mehta,et al. Possible involvement of Bcl-2 pathway in retinoid X receptor alpha-induced apoptosis of HL-60 cells. , 1997, Biochemical and biophysical research communications.
[3] Y. Hiraku,et al. Oxidative DNA damage and apoptosis induced by benzene metabolites. , 1996, Cancer research.
[4] J. Ernst,et al. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. , 1996, The Journal of clinical investigation.
[5] P. Chambon,et al. RXRalpha‐null F9 embryonal carcinoma cells are resistant to the differentiation, anti‐proliferative and apoptotic effects of retinoids. , 1996, The EMBO journal.
[6] John Calvin Reed,et al. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. , 1996, Cancer research.
[7] M. Tomonaga,et al. Relation of oxidative stress and glutathione synthesis to CD95(Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells. , 1996, Journal of immunology.
[8] J. Yodoi,et al. Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. , 1996, The Journal of clinical investigation.
[9] T. McDonnell,et al. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. , 1996, Journal of immunology.
[10] I. Kanazawa,et al. Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells , 1996, The Journal of cell biology.
[11] S. Castro-Obregón,et al. Role of retinoic acid and oxidative stress in embryonic stem cell death and neuronal differentiation , 1996, FEBS letters.
[12] R. Ozols,et al. Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a Phase I trial of melphalan and BSO. , 1995, Cancer research.
[13] V. Ferrans,et al. Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction , 1995, Science.
[14] W. Hong,et al. Induction of apoptosis by retinoids in human cervical-carcinoma cell-lines. , 1995, International journal of oncology.
[15] G. Shipley,et al. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines , 1995, Molecular and cellular biology.
[16] T. Buttke,et al. Redox regulation of programmed cell death in lymphocytes. , 1995, Free radical research.
[17] M. Dawson,et al. Evidence for the Involvement of Retinoic Acid Receptor RAR-dependent Signaling Pathway in the Induction of Tissue Transglutaminase and Apoptosis by Retinoids (*) , 1995, The Journal of Biological Chemistry.
[18] S. Nagata,et al. The Fas death factor , 1995, Science.
[19] Y. Yamaoka,et al. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. , 1994, Immunology letters.
[20] M. Vora,et al. Retinoids upregulate phagocytosis by human dermal microvascular endothelial cells , 1994, Journal of cellular physiology.
[21] V. Giguère. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. , 1994, Endocrine reviews.
[22] Z. Oltvai,et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.
[23] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.
[24] T. Honjo,et al. Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. , 1992, The EMBO journal.
[25] M. Roederer,et al. N-acetylcysteine: a new approach to anti-HIV therapy. , 1992, AIDS research and human retroviruses.
[26] H. Nakamura,et al. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. , 1991, Journal of immunology.
[27] P. Moldéus,et al. The metabolism of N-acetylcysteine by human endothelial cells. , 1991, Biochemical pharmacology.
[28] I Nicoletti,et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.
[29] M. Roederer,et al. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Mckeown,et al. Relationship between the product of the Drosophila ultraspiracle locus and the vertebrate retinoid X receptor , 1990, Nature.
[31] R. Evans,et al. Nuclear receptor that identifies a novel retinoic acid response pathway , 1990, Nature.
[32] G. Wong,et al. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor , 1989, Cell.
[33] J. Wood,et al. The stereospecific suicide inhibition of human melanoma thioredoxin reductase by 13-cis-retinoic acid. , 1989, Biochemical and biophysical research communications.
[34] K. Arai,et al. ATL‐derived factor (ADF), an IL‐2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol‐reduction in the IL‐2 receptor induction. , 1989, The EMBO journal.
[35] K. Asada,et al. [Metabolism and function of glutathione in plants]. , 1988, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[36] Pierre Chambon,et al. A human retinoic acid receptor which belongs to the family of nuclear receptors , 1987, Nature.
[37] V. Giguère,et al. Identification of a receptor for the morphogen retinoic acid , 1987, Nature.
[38] J. Wood,et al. The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. , 1986, Biochemical and biophysical research communications.
[39] M. Winker,et al. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. , 1985, Biochemical pharmacology.
[40] S. Collins,et al. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[41] S. Strickland,et al. The induction of differentiation in teratocarcinoma stem cells by retinoic acid , 1978, Cell.
[42] John Calvin Reed,et al. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. , 1995, Blood.
[43] H. Nakamura,et al. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors. , 1995, Oncology research.
[44] T. Buttke,et al. Oxidative stress as a mediator of apoptosis. , 1994, Immunology today.
[45] P Chambon,et al. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Yodoi,et al. Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. , 1992, Immunology today.
[47] H. Nakamura,et al. Lymphocyte transformation and thiol compounds; the role of ADF/thioredoxin as an endogenous reducing agent. , 1992, Molecular Immunology.
[48] M. Sporn,et al. Cellular biology and biochem-istry of the retinoids , 1984 .